These findings indicate that CRMP1 may have beneficial effects against neurodegenerative diseases, including HD and ALS, although the molecular mechanism of the decrease in CRMP1/Crmp1 in patients and mouse models is currently unknown. Here, CRMP1 is linked to Huntington disease.